← Evidence map

ArticleHaematologica2025

Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy.

Sarah Cadot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy. | OpenQuestion